Cardiovascular Diseases

Adults taking medications that cross the blood-brain barrier had better memory recall.

Chances of left ventricular ejection fraction almost disappeared when patient took the ACE-inhibitor lisinopril during treatment with trastuzumab/anthracycline, according to research presented at ASCO.

The study, which will be presented next week during the 70th American College of Cardiology Scientific Session, is the first to examine how chest pain is managed among adults who are too young for Medicare.

The AstraZeneca drug is the first SGLT2 inhibitor approved for chronic kidney disease regardless of whether the patient has diabetes.

Paying attention to the social determinants of health may be a powerful way of improving cardiovascular outcomes.

Access to care and other health disparities result in the low use of novel therapies for Black, female and lower income type 2 diabetes patients. If these barriers aren't addressed, disparities among kidney and cardiovascular patients may worsen in the U.S.

Application was submitted for both the 81 and 325 mg doses of the liquid-filled capsule formulation of aspirin.

The FDA approved the use of Entresto in a broader group of heart failure patients that includes a large percentage of those with preserved ejection fraction.

February is American Heart Month and the perfect time to think about our cardiovascular health. Cardiovascular diseases are those that affect the heart and blood vessels and include stroke, coronary artery disease (CAD), heart failure, and other poor heart and vascular health outcomes.

Novartis says the drug may be appropriate for five out of six Americans with chronic heart failure.

The approval come following the results of a phase 3 trial.

The prevalence of heart failure is increasing as the demographic profile of the American population gets older.

Attention is turning this year to heart failure with preserved injection fraction.

A remote monitoring system detects indicators of worsening heart failure.

Philip Adamson, M.D., M.Sc., details the relationship between cardiovascular manifestations and COVID-19.

Using AI and real-world data, investigators identify drugs that can be used to treat heart disease.

New study findings demonstrate patients with treatment-resistant hypertension rarely get tested for primary aldosteronism.

The panel supports an expanded indication but struggles to reach consensus on what an expanded label might look like.

The NDA submission comes following the results of a phase 3a trial.

Women have an increased risk of heart disease in the years leading up to menopause.

The idea that social factors affect health outcomes is not new, but new research suggests total number of social determinants of health is a valuable proxy for coronary heart disease risk.

Women are disproportionately affected by heart failure after heart attacks, according to a Canadian study.

While glucocorticoids are widely used to reduce inflammation in patients with many inflammatory diseases, doctors don’t know whether a low to moderate glucocorticoid dose increases cardiovascular risk.

FDA approves several drugs to treat rare conditions in both cancer and metabolic diseases.